SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
yanyan
Lv1
70 积分
2024-01-05 加入
最近求助
最近应助
互助留言
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
6天前
已完结
Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma
6天前
已完结
Physical torment: A predisposition for diffuse B-cell lymphoma
7天前
已完结
Patient‐reported outcomes provide prognostic information for survival in patients with diffuse large B‐cell lymphoma: Analysis of 1239 patients from the GOYA study
7天前
已完结
The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi
7天前
已完结
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial
7天前
已完结
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
7天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
10天前
已完结
Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options
14天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
17天前
已完结
没有进行任何应助
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论